February 28, 2017 / 7:20 AM / 7 months ago

BRIEF-Karo Pharma turns to Q4 EBITDA profit

Feb 28 (Reuters) - Karo Pharma Ab

* Says net sales amounted to MSEK 347.3 (69.1), whereof Q4 MSEK 96.5 (57.4)

* Says EBITDA was MSEK 51.7 (-71.7), whereof Q4 MSEK 28.9 (-22.3) Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below